totally agree Mo

and imo the timing couldn't be better ..

it's rare imo for most OTC targets to exploit those who exploit them by rote
this is one of those times for Innovation Pharma's mgmt .. specifically from
now into September .. and then September into EOY ..

as i've noted to those who have asked .. i have remained an investor in Innovation
Pharma for 2 reasons .. first is the company's diversity of platform (potential)
which imo is unique in its own right .. the second remains mgmt's aggressive
response of 2015 .. also unique to the OTC .. imo most of OTC mgmt teams
are *clueless* .. literally until it is almost too late for them ..

perhaps just me but I don't see that lack of awareness with IP

4kids

Quote:

---

This is a calculated effort by Leo. Note the timing of the BOD voting on the authorized share increase on 7/17/19 and the next day 7/18/19 sign the Alphasigma agreement. Leo has been consistent in balancing the advancement of $IPIX science while minimizing shareholder dilution. Authorized shares are not dilutive until they are issued. I have confidence that IPIX will only issue additional shares for strategic initiates that will greatly improve shareholder ROI. Long term IPIX investors have witnessed this for many years and that is why Longs have not been selling. A lack of real shares on the supply side has made NR continue to dig their hole by increasing counterfeit shares. I am excited to watch as Leo’s strategic plan gets methodically unveiled and I especially like the quote:

“In addition, we may issue shares to acquire other companies or assets or engage in business combination transactions.”

---